Deutsche Bank’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-27,173
| Closed | -$236K | – | 5726 |
|
|
2018
Q2 | $236K | Sell |
27,173
-20,538
| -43% | -$185K | ﹤0.01% | 4215 |
|
|
2018
Q1 | $484K | Buy |
47,711
+10,530
| +28% | +$88.5K | ﹤0.01% | 3719 |
|
|
2017
Q4 | $180K | Buy |
37,181
+19,653
| +112% | +$95.6K | ﹤0.01% | 4074 |
|
|
2017
Q3 | $79K | Buy |
+17,528
| New | +$82.3K | ﹤0.01% | 4247 |
|
|
2017
Q2 | – | Sell |
-18,300
| Closed | -$86K | – | 5262 |
|
|
2017
Q1 | $86K | Buy |
18,300
+600
| +3% | +$3.03K | ﹤0.01% | 3991 |
|
|
2016
Q4 | $99K | Hold |
17,700
| – | – | ﹤0.01% | 4088 |
|
|
2016
Q3 | $98K | Hold |
17,700
| – | – | ﹤0.01% | 3950 |
|
|
2016
Q2 | $124K | Hold |
17,700
| – | – | ﹤0.01% | 4002 |
|
|
2016
Q1 | $116K | Buy |
17,700
+8,500
| +92% | +$62.6K | ﹤0.01% | 3933 |
|
|
2015
Q4 | $94K | Buy |
+9,200
| New | +$107K | ﹤0.01% | 4095 |
|
|
2015
Q3 | – | Sell |
-8,161
| Closed | -$74K | – | 5462 |
|
|
2015
Q2 | $74K | Sell |
8,161
-12,282
| -60% | -$92.8K | ﹤0.01% | 4396 |
|
|
2015
Q1 | $126K | Buy |
20,443
+16,142
| +375% | +$99.8K | ﹤0.01% | 4030 |
|
|
2014
Q4 | $24K | Buy |
+4,301
| New | +$25K | ﹤0.01% | 5458 |
|
|
2014
Q3 | – | Sell |
-88
| Closed | – | – | 6226 |
|
|
2014
Q2 | $0 | Buy |
+88
| New | +$589 | ﹤0.01% | 6191 |
|
|
2014
Q1 | – | Sell |
-19,463
| Closed | -$128K | – | 5900 |
|
|
2013
Q4 | $128K | Sell |
19,463
-71,045
| -78% | -$484K | ﹤0.01% | 3931 |
|
|
2013
Q3 | $657K | Buy |
+90,508
| New | +$609K | ﹤0.01% | 3292 |
|
Deutsche Bank's JNP Position: Q3 2018 in Review
Deutsche Bank sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 27,173 shares — an estimated $236K sold.
Deutsche Bank first reported a position in JNP in Q3 2013 and held it in 16 quarters. The position peaked at $657K in Q3 2013. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Deutsche Bank reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Deutsche Bank sold 27,173 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $236K.
- Deutsche Bank first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 16 quarters.
- Deutsche Bank's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $657K in Q3 2013.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.